Stephen Jarrett

1.1k total citations
9 papers, 575 citations indexed

About

Stephen Jarrett is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Stephen Jarrett has authored 9 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Hematology. Recurrent topics in Stephen Jarrett's work include Vasculitis and related conditions (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Otitis Media and Relapsing Polychondritis (2 papers). Stephen Jarrett is often cited by papers focused on Vasculitis and related conditions (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Otitis Media and Relapsing Polychondritis (2 papers). Stephen Jarrett collaborates with scholars based in United Kingdom, United States and Belgium. Stephen Jarrett's co-authors include Philip G. Conaghan, Paul Emery, Mark Quinn, Sarah Bingham, Gaye Cunnane, Maya H Buch, Dennis McGonagle, Philip O’Connor, Victor S. Sloan and P. Papanastasiou and has published in prestigious journals such as Diabetes Care, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Stephen Jarrett

9 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Jarrett United Kingdom 9 409 138 104 89 86 9 575
Pascale Schwab United States 11 178 0.4× 41 0.3× 63 0.6× 93 1.0× 91 1.1× 18 457
Vincenzo Pitini Italy 15 190 0.5× 183 1.3× 162 1.6× 141 1.6× 92 1.1× 48 729
C McClinton United Kingdom 11 571 1.4× 209 1.5× 28 0.3× 45 0.5× 181 2.1× 14 714
Michael Borofsky United States 8 171 0.4× 79 0.6× 48 0.5× 36 0.4× 59 0.7× 15 447
I. Monjo Spain 14 360 0.9× 45 0.3× 266 2.6× 55 0.6× 148 1.7× 59 568
Hilde Swinkels Netherlands 8 1.2k 2.9× 320 2.3× 36 0.3× 69 0.8× 164 1.9× 9 1.3k
Suzanne P. Linn-Rasker Netherlands 9 748 1.8× 132 1.0× 47 0.5× 59 0.7× 139 1.6× 14 979
I C van Eijk Netherlands 12 483 1.2× 102 0.7× 65 0.6× 162 1.8× 179 2.1× 13 614
Anna‐Birgitte Aga Norway 14 662 1.6× 232 1.7× 25 0.2× 71 0.8× 117 1.4× 44 762
Esmeralda T. H. Molenaar Netherlands 11 652 1.6× 235 1.7× 17 0.2× 61 0.7× 130 1.5× 15 775

Countries citing papers authored by Stephen Jarrett

Since Specialization
Citations

This map shows the geographic impact of Stephen Jarrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Jarrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Jarrett more than expected).

Fields of papers citing papers by Stephen Jarrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Jarrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Jarrett. The network helps show where Stephen Jarrett may publish in the future.

Co-authorship network of co-authors of Stephen Jarrett

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Jarrett. A scholar is included among the top collaborators of Stephen Jarrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Jarrett. Stephen Jarrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Harrison, Stephanie R, Dennis McGonagle, Stephen Jarrett, et al.. (2016). Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology. JCI Insight. 1(6). e86336–e86336. 47 indexed citations
2.
Mackie, Sarah, John Taylor, Stephen G. Martin, et al.. (2015). Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation. Arthritis Research & Therapy. 17(1). 195–195. 34 indexed citations
3.
Jarrett, Stephen, et al.. (2013). Renal cell carcinoma-associated adult dermatomyositis treated laparoscopic nephrectomy. Urology Annals. 5(4). 299–299. 8 indexed citations
4.
Mackie, Sarah, Bhaskar Dasgupta, Lesley Hordon, et al.. (2011). Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors. Lara D. Veeken. 50(11). 2014–2022. 30 indexed citations
5.
Bejarano, Victoria, Mark Quinn, Philip G. Conaghan, et al.. (2008). Effect of the early use of the anti–tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis Care & Research. 59(10). 1467–1474. 136 indexed citations
6.
Saleem, Benazir, Sarah Mackie, M. Quinn, et al.. (2008). Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis?. Annals of the Rheumatic Diseases. 67(8). 1178–1180. 49 indexed citations
7.
Jarrett, Stephen, Philip G. Conaghan, Victor S. Sloan, et al.. (2006). Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis & Rheumatism. 54(5). 1410–1414. 120 indexed citations
8.
Tan, Ai Lyn, Adam Greenstein, Stephen Jarrett, & Dennis McGonagle. (2005). Acute Neuropathic Joint Disease. Diabetes Care. 28(12). 2962–2964. 18 indexed citations
9.
Jarrett, Stephen, Gaye Cunnane, Philip G. Conaghan, et al.. (2003). Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series.. PubMed. 30(10). 2287–91. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascale Schwab Breakdown of academic impact, for papers by Vincenzo Pitini Breakdown of academic impact, for papers by C McClinton Breakdown of academic impact, for papers by Michael Borofsky Breakdown of academic impact, for papers by I. Monjo Breakdown of academic impact, for papers by Hilde Swinkels Breakdown of academic impact, for papers by Suzanne P. Linn-Rasker Breakdown of academic impact, for papers by I C van Eijk Breakdown of academic impact, for papers by Anna‐Birgitte Aga Breakdown of academic impact, for papers by Esmeralda T. H. Molenaar
Rankless by CCL
2026